Explore Rankings
Journal profile · Economics, Econometrics and Finance

Current Opinion in Pharmacology

Elsevier BV · United Kingdom · ISSN 1471-4892, 1471-4973

ITS Journal Score78.3
Global rank#2,760
Rank in Economics, Econometrics and Finance#72 of 1,830
h-index175
Open access 2021–202544%

Overview

Current Opinion in Pharmacology, published by Elsevier BV (United Kingdom), published 404 papers in 2021–2025, and its papers received 6,252 citations in those years. Its h-index is 175 and its two-year mean citedness is 4.04. On the ITS Journal Score it ranks #2,760 of 62,158 ranked journals and #72 of 1,830 in Economics, Econometrics and Finance.

Key figures

Papers 2021–2025404
Citations 2021–20256,252
Citations per paper15.5
h-index175
i10-index2,110
2-year mean citedness4.04
Open-access share44%
Change in papers, 2020→2025-51%
Article fee (APC)Not recorded

Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.

Papers and citations by year

YearPapersCitations receivedOpen-access papers
20201213,03755
20211362,86753
20221272,32964
20234150321
20244139222
20255916117

What it publishes

The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.

Similar journals

Ranked journals that publish on the same topics.

JournalFieldScorePapers 2021–2025Open access
Translational researchEconomics, Econometrics and Finance75.377046%
Pharmacological ReviewsEconomics, Econometrics and Finance91.629872%
Disease-a-MonthEconomics, Econometrics and Finance65.24719%
Pharmacology & TherapeuticsBiochemistry, Genetics and Molecular Biology90.073844%
Materials Science and Engineering R ReportsEngineering90.540326%
ComputerComputer Science73.52,28853%
IETE Journal of ResearchEngineering68.22,0035%
Current problems in pediatric and adolescent health careEngineering65.539821%

Compare with similar journals (side by side with the two closest journals above)

Identity and sources

  • ISSN-L: 1471-4892
  • Print ISSN: 1471-4892
  • Electronic ISSN: 1471-4973
  • Publisher: Elsevier BV
  • Listed in DOAJ: Not yet checked
  • Crossref: ISSN found in Crossref
  • OpenAlex: S13215328
  • Journal website: www.journals.elsevier.com

Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.

Questions

What is the ITS Journal Score of Current Opinion in Pharmacology?

It is 78.3 out of 100, which places it #2,760 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.

What is the impact factor of Current Opinion in Pharmacology?

This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 4.04.

Is Current Opinion in Pharmacology open access?

44% of its papers from 2021–2025 are recorded as open access.

Does Current Opinion in Pharmacology charge a publication fee?

No fee is recorded in the open data used here. Check the journal's own website for its current fees.

Transparent methodology

How the ITS Journal Score works

One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.

A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.

What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.